Next Generation ICM Offers Remote Programming with Improved Longevity and Enhanced Accuracy DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, ...

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...

Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...

Medtronic plc MDT recently announced the receipt of the FDA approval and the CE Mark for its LINQ II insertable cardiac monitor (“ICM”) with remote programming. Notably, ICM is a new long-term ...

So, just what are the technologies that stand out in design and are on the cutting edge? That question was answered, and the devices were revealed at the Medical Design Excellence Awards during the ...

Medtronic said its AccuRhythm AI algorithm technology is the winner of the 7 th annual MedTech Breakthrough Awards program as the "Best New Monitoring Solution." AccuRhythm AI is an artificial ...

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...

Medtronic plc MDT recently announced the receipt of the FDA approval and the CE Mark for its LINQ II insertable cardiac monitor (“ICM”) with remote programming. Notably, ICM is a new long-term ...

DUBLIN, July 07, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT), the global leader in medical technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance and CE ...

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...